Abstract | BACKGROUND: Studies have suggested some benefit of 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors in congestive heart failure (CHF), although the mechanisms remain uncertain. We hypothesized that statins could improve pulmonary hypertension and right ventricular function in ischemic CHF by reducing lung remodeling. METHODS AND RESULTS: CONCLUSIONS:
|
Authors | Bao Hua Jiang, Jean-Claude Tardif, Stephanie Sauvageau, Anique Ducharme, Yanfen Shi, James G Martin, Jocelyn Dupuis |
Journal | Journal of cardiac failure
(J Card Fail)
Vol. 16
Issue 8
Pg. 679-88
(Aug 2010)
ISSN: 1532-8414 [Electronic] United States |
PMID | 20670847
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright (c) 2010 Elsevier Inc. All rights reserved. |
Chemical References |
- Heptanoic Acids
- Pyrroles
- Atorvastatin
|
Topics |
- Animals
- Atorvastatin
- Cells, Cultured
- Heart Failure
(drug therapy, pathology, physiopathology)
- Heptanoic Acids
(administration & dosage, therapeutic use)
- Lung
(drug effects, physiopathology)
- Myocardial Infarction
(drug therapy, pathology, physiopathology)
- Myofibroblasts
(drug effects, pathology, physiology)
- Pyrroles
(administration & dosage, therapeutic use)
- Random Allocation
- Rats
- Respiratory Function Tests
|